Pharma & Biopharma Manufacturing
Sirio Pharma and Best Formulations Announce U.S. Gummy Manufacturing Capabilities
Sirio Pharma Co., Ltd. (Sirio), a leading global CDMO, is pleased to announce the addition of new gummy manufacturing capabilities at its Best Formulations...
October 20, 2023 | News
WuXi Biologics Introduces WuXiUI™: Enhancing Bioprocessing for Efficiency and Quality in Commercial Manufacturing
WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics d...
October 17, 2023 | News
Coriolis Pharma Announces Strategic Growth Partnership With KKR and Frontier Biosolutions
Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint Newly formed KKR platform Frontier Biosolutio...
October 16, 2023 | News
ABL Bio Achieves Regulatory Clearance for Innovative Bispecific Antibody in Solid Tumor; GenScript ProBio Commends Milestone Collaboration
ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...
October 13, 2023 | News
CSL Inks Renewable Power Deal with AGL for Australian Manufacturing
The agreement will significantly advance CSL's Scope 1 & 2 emissions reductions with all electricity used by CSL's Australian manufacturing sites ...
October 12, 2023 | News
GC Biopharma Signs Power Purchase Agreement with SK E&S
PPA is an electricity trading contract signed directly between a power generator and a customer company. Under this agreement, the company can purchase and...
October 11, 2023 | News
Thermo Fisher Scientific Expands St. Louis Manufacturing for Complex Biologic Treatments
Thermo Fisher Scientific, the world leader in serving science, expanded its manufacturing capacity in St. Louis to support biologic therapies for dis...
October 06, 2023 | News
Cytiva opens new manufacturing facility and experience center in India
· The manufacturing facility in Pune will double Cytiva’s manufacturing capacity in India and the Exp...
October 05, 2023 | News
LOTTE BIOLOGICS Acquires Land in Songdo with Incheon Free Economic Zone Authority
Construction of a Bio Plant with a total production capacity of 360 kL at Songdo's Block KI20, Zone 11 by 2030 Aims to secure capabilities of an interna...
October 05, 2023 | News
OBiO Launches GMP Facility Intelli-M for Rapid Delivery of Innovative Therapies
The launch of the new base in Shanghai will enhance OBiO's production and service capabilities in both China and the United States...
September 28, 2023 | News
Besins Healthcare Opens Advanced Hormone Factory in Spain, Boosts Global Output by 30%
Besins Healthcare, a global lead in Women's and Men's Reproductive Health, today unveiled its novel hormone production facility in Muel, situated near Zara...
September 28, 2023 | News
WuXi Vaccines Launches Its First Vaccines CDMO Site in China
The opening will add drug substance and drug product capacity, with end-to-end services for diversified vaccines that will accelerate global clients' proje...
September 27, 2023 | News
Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals
Biosynth, a supplier of critical materials to the life science industry, is pleased to announce the acquisition of Pepceuticals, a UK producer of synthetic...
September 26, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
